Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001045664 | SCV001209530 | benign | Nemaline myopathy 2 | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004031407 | SCV004979412 | uncertain significance | Inborn genetic diseases | 2023-12-15 | criteria provided, single submitter | clinical testing | The c.19966G>A (p.G6656S) alteration is located in exon 150 (coding exon 148) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 19966, causing the glycine (G) at amino acid position 6656 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001045664 | SCV002083925 | uncertain significance | Nemaline myopathy 2 | 2020-12-14 | no assertion criteria provided | clinical testing |